Novocure Ltd
NASDAQ:NVCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novocure Ltd
NASDAQ:NVCR
|
JE |
Intrinsic Value
The intrinsic value of Novocure Ltd (NVCR) under the Base Case is 28.024 USD per share.
Compared with the current market price of 14.215 USD, the stock appears
Undervalued by 49% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Novocure Does
Novocure makes Tumor Treating Fields therapy, a non-invasive cancer treatment that uses a portable wearable device and adhesive arrays placed on the skin to send low-intensity electric fields to tumors. Its main product is the NovoTTF system, which is used with standard cancer care for certain solid tumors, especially in settings where patients can treat themselves at home under a doctor’s guidance.
- Headquarters
- Jersey JE
- Employees
- 1 605
- IPO date
- Oct 1, 2015
Revenue & Expenses Breakdown
Novocure Ltd
Earnings Waterfall
Novocure Ltd
The intrinsic value for Novocure Ltd (NVCR) under the Base Case is 28.024 USD.
Compared with the current market price of 14.215 USD, the stock appears Undervalued by 49% .